Who owns the DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark?

The DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark is owned by Innovo Therapeutics Inc..

What class is the DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark registered in?

The DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for DEEPZEMA AI-AUGMENTED DRUG DISCOVERY?

The USPTO serial number for DEEPZEMA AI-AUGMENTED DRUG DISCOVERY is 79308937.

What is the registration number for DEEPZEMA AI-AUGMENTED DRUG DISCOVERY?

DEEPZEMA AI-AUGMENTED DRUG DISCOVERY is registered under USPTO registration number 6720808.

DEE

USPTO Trademark Record

REGISTERED

DEEPZEMA AI-AUGMENTED DRUG DISCOVERY

SN 79308937·Reg 6720808·Filed Feb 23, 2021

Owner Innovo Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DEEPZEMA AI-AUGMENTED DRUG DISCOVERY (Serial No. 79308937), Registration No. 6720808, is a registered US trademark filed on Feb 23, 2021 by Innovo Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: May 24, 2028

Mark Intelligence

DEEPZEMA AI-AUGMENTED DRUG DISCOVERY (Reg. #6720808) is a registered US trademark that has been protecting its owner, Innovo Therapeutics Inc., since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 3 opposition proceedings during prosecution.

FILED

Feb 23, 2021

SERIAL

79308937

REG#

6720808

REGISTERED

May 24, 2022

Owner

Applicant

Innovo Therapeutics Inc.

Entity

Not Provided

Address

16F B-10, 402, World Cup buk-ro, Mapo-gu, Seoul 03925

Country

Attorney

NameCynthia A. Moyer

Law firm

Cynthia A. Moyer Fredrikson & Byron, P.A.

Docket

57428.0084

Address

200 South Sixth Street, Suite 4000, Minneapolis, MN 55402, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 23, 2021

Serial Number79308937

Registration No.6720808

Registration DateMay 24, 2022

Status DateMay 24, 2022

Published for OppositionFeb 22, 2022

Mark TypeStylized characters

Attorney Docket57428.0084

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 02, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Sep 10, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Sep 09, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Aug 24, 2022

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

May 24, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 24, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 22, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 22, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Feb 20, 2022

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 02, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Feb 02, 2022

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 02, 2022

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 18, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 13, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 12, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 12, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Nov 15, 2021

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 24, 2021

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Oct 15, 2021

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 28, 2021

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 27, 2021

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 17, 2021

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Apr 20, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 16, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 15, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

DEEPZEMA AI-AUGMENTED DRUG DISCOVERY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Innovo Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Cynthia A. Moyer

Resources

Company